1. Home
  2. CLLS vs PKBK Comparison

CLLS vs PKBK Comparison

Compare CLLS & PKBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • PKBK
  • Stock Information
  • Founded
  • CLLS 1999
  • PKBK 1999
  • Country
  • CLLS France
  • PKBK United States
  • Employees
  • CLLS N/A
  • PKBK N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • PKBK Major Banks
  • Sector
  • CLLS Health Care
  • PKBK Finance
  • Exchange
  • CLLS Nasdaq
  • PKBK Nasdaq
  • Market Cap
  • CLLS 240.2M
  • PKBK 244.2M
  • IPO Year
  • CLLS 2007
  • PKBK N/A
  • Fundamental
  • Price
  • CLLS $2.01
  • PKBK $20.74
  • Analyst Decision
  • CLLS Buy
  • PKBK
  • Analyst Count
  • CLLS 2
  • PKBK 0
  • Target Price
  • CLLS $8.00
  • PKBK N/A
  • AVG Volume (30 Days)
  • CLLS 22.3K
  • PKBK 24.8K
  • Earning Date
  • CLLS 11-04-2024
  • PKBK 10-23-2024
  • Dividend Yield
  • CLLS N/A
  • PKBK 3.47%
  • EPS Growth
  • CLLS N/A
  • PKBK N/A
  • EPS
  • CLLS N/A
  • PKBK 1.80
  • Revenue
  • CLLS $19,635,000.00
  • PKBK $64,605,999.00
  • Revenue This Year
  • CLLS $271.02
  • PKBK N/A
  • Revenue Next Year
  • CLLS $33.48
  • PKBK N/A
  • P/E Ratio
  • CLLS N/A
  • PKBK $11.17
  • Revenue Growth
  • CLLS N/A
  • PKBK N/A
  • 52 Week Low
  • CLLS $0.96
  • PKBK $15.16
  • 52 Week High
  • CLLS $3.77
  • PKBK $22.00
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 41.74
  • PKBK 50.45
  • Support Level
  • CLLS $1.95
  • PKBK $19.55
  • Resistance Level
  • CLLS $2.06
  • PKBK $20.47
  • Average True Range (ATR)
  • CLLS 0.10
  • PKBK 0.38
  • MACD
  • CLLS -0.01
  • PKBK -0.12
  • Stochastic Oscillator
  • CLLS 33.33
  • PKBK 50.56

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.

About PKBK Parke Bancorp Inc.

Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.

Share on Social Networks: